Medicare Enrolled
Dr. Jason Brajer, M.D.
Pain Medicine · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Brajer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brajer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Brajer
Dr. Jason Brajer is a pain medicine specialist in Bryn Mawr, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Brajer performed 6,344 Medicare services across 2,306 unique beneficiaries.
Between the years covered by Open Payments, Dr. Brajer received a total of $5,625 from 41 pharmaceutical and/or device companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Brajer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 33% volume in PA
$5,625 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,344
Medicare services
Top 33% in PA for pain medicine
2,306
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~317 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
1,536 | $60 | $186 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,152 | $93 | $369 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
900 | $191 | $596 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
658 | $17 | $68 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
368 | $240 | $741 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
271 | $0 | $3 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
234 | $150 | $470 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
154 | $127 | $511 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
151 | $120 | $480 |
| Psychological or neuropsychological test, first 30 minutes Administration of psychological or neuropsychological testing for the first 30 minutes. |
133 | $32 | $139 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
114 | $67 | $245 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
105 | $107 | $343 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
79 | $191 | $623 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
78 | $102 | $356 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
46 | $68 | $269 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
40 | $55 | $189 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
35 | $162 | $632 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
32 | $491 | $1,402 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
32 | $274 | $827 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
30 | $202 | $784 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
29 | $25 | $96 |
| Remote therapy monitoring setup and education This service involves setting up equipment and providing patient education for the remote monitoring of therapy. |
29 | $14 | $54 |
| Musculoskeletal remote monitoring device supply, 30 days A device supply that records and transmits data for remote monitoring of the musculoskeletal system over a 30-day period. |
29 | $36 | $140 |
| Electronic analysis of spinal drug pump An electronic evaluation of a spinal canal drug infusion pump to check its function and settings. |
28 | $24 | $99 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
28 | $111 | $468 |
| Remote therapeutic monitoring, first 20 minutes Physician management of remote therapeutic monitoring data for the first 20 minutes per calendar month. |
27 | $37 | $143 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
13 | $176 | $982 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
13 | $80 | $528 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,625
Total received (2018-2024)
Avg $804/year across 7 years
Top 24% in PA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
197
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,625 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$998
2023
$1,002
2022
$879
2021
$563
2020
$479
2019
$611
2018
$1,093
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$358
ABBVIE INC.
$249
Collegium Pharmaceutical, Inc.
$210
Zimmer Biomet Holdings, Inc.
$49
Averitas Pharma Inc.
$49
Bioventus LLC
$39
PFIZER INC.
$29
VERTEX PHARMACEUTICALS INCORPORATED
$16
Top 3 companies account for 81.8% of 2024 payments
All-time payments by company (2018-2024) ›
Abbott Laboratories
$920
Medtronic, Inc.
$605
Nevro Corp.
$585
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$394
Collegium Pharmaceutical, Inc.
$365
Medtronic USA, Inc.
$267
ABBVIE INC.
$249
Nuvectra Corporation
$247
Teva Pharmaceuticals USA, Inc.
$226
AbbVie Inc.
$168
PFIZER INC.
$145
Vertos Medical, Inc.
$143
SPR Therapeutics, Inc
$113
Averitas Pharma Inc.
$110
Pernix Therapeutics Holdings, Inc.
$95
Stimwave Technologies Incorporated
$88
Relievant Medsystems, Inc.
$85
BioDelivery Sciences International, Inc.
$80
Lilly USA, LLC
$75
Biohaven Pharmaceutical Holding Company Ltd.
$63
Iroko Pharmaceuticals, LLC
$58
SI-BONE, Inc.
$51
GRT US Holding, Inc.
$50
Zimmer Biomet Holdings, Inc.
$49
Boston Scientific Corporation
$45
Daiichi Sankyo Inc.
$41
Bioventus LLC
$39
Amgen Inc.
$32
IBSA Pharma Inc.
$29
Scilex Pharmaceuticals Inc.
$29
SI-BONE, INC.
$29
Foundation Fusion Solutions, LLC
$22
TerSera Therapeutics LLC
$19
Avanos Medical
$18
VERTEX PHARMACEUTICALS INCORPORATED
$16
ARBOR PHARMACEUTICALS, INC.
$14
Biohaven Pharmaceuticals, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$12
Forte Bio-Pharma LLC
$12
Upsher-Smith Laboratories LLC
$12
Supernus Pharmaceuticals, Inc.
$11
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
AJOVY · AUSTEDO · Algovita · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · COMIRNATY · DUROLANE · EMGALITY · GENERAL PAIN MANAGEMENT · Gel-One Cross-linked Hyaluronate · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · LYRICA · Licart · MOUNJARO · Morphabond ER · NALOCET · NURTEC ODT · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Proclaim Plus SCS with FlexBurst360 · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · Qutenza · RELISTOR · SPRINT PNS System · SYNCHROMED · Senza Spinal Cord Stimulation System · TRIVISC SODIUM HYALURONATE · TROKENDI XR · TRULICITY · Tirosint · Trintellix · UBRELVY · VECTRIS · VIVLODEX · VRAYLAR · WaveWriter Alpha Prime 16 · XIFAXAN · XTAMPZA · Xtampza ER · ZOHYDRO ER · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicines within 10 mi
18
Per 100K population
3.1
County median income
$88,576
Nearest hospital
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Brajer is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Brajer experienced with drug screening test?
Based on Medicare claims data, Dr. Brajer performed 1,536 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brajer receive payments from pharmaceutical companies?
Yes. Dr. Brajer received a total of $5,625 from 41 companies across 197 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brajer's costs compare to other pain medicines in Bryn Mawr?
Dr. Brajer's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brajer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Bryn Mawr
Browse pain medicines in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in PA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in PA
Which PA pain medicines receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology